CompaniesIncyte

Incyte

active

Wilmington, DE, United States

Founded 2001

About

Small Molecules

Areas of Focus

Categories

Small Molecule PharmaceuticalVirginia, DC, DE & Maryland

Team (10)

EDMUND P. HARRIGAN, M.D.

HERVÉ HOPPENOT

JACQUALYN A. FOUSE, PH.D.

JEAN-JACQUES BIENAIMÉ

JULIAN C. BAKER

View all 10 team members →

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

66

By Phase

PHASE1/PHASE2: 1

By Status

NOT_YET_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2025

2026

2027

2028

2029

2030

2031

2032

2033

2034

Today

Hover over trial bars to see details

Recent Trials

NCT07128381Collaborator

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

PHASE1/PHASE2Not yet recruiting

66 participants

Started: Jan 31, 2026 · Completed: Jul 31, 2033

Funding History (20)

8-K

Oct 3, 2025

8-K

Aug 7, 2025

8-K

Jul 29, 2025

8-K

Jun 27, 2025

8-K

Jun 11, 2025

8-K

May 14, 2025

DEFA14A

Apr 29, 2025

DEF 14A

Apr 29, 2025

8-K

Apr 29, 2025

8-K

Feb 10, 2025

Locations (1)

Headquarters

Wilmington, DE, United States

Map

Loading map...